Literature DB >> 3891627

Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.

S Kotani, H Takada, M Tsujimoto, T Ogawa, I Takahashi, T Ikeda, K Otsuka, H Shimauchi, N Kasai, J Mashimo.   

Abstract

A synthetic compound (506), beta (1-6) D-glucosamine disaccharide 1,4'-bisphosphate, which is acylated at 2'-amino and 3'-hydroxyl groups with (R)-3-dodecanoyloxytetradecanoyl and (R)-3-tetradecanoyloxytetradecanoyl groups, respectively, and has (R)-3-hydroxytetradecanoyl groups at 2-amino and 3-hydroxyl groups, exhibited full endotoxic activities identical to or sometimes stronger than those of a reference lipid A from an Escherichia coli Re-mutant (strain F515). Endotoxic activities tested include pyrogenicity and leukopenia-inducing activity in rabbits, body weight-decreasing toxicity in normal mice, lethal toxicity in galactosamine-sensitized mice and chicken embryos, and the preparation and provocation of the local Shwartzman reaction in rabbits. Compound 406, a synthetic counterpart of a biosynthetic precursor of lipid A molecule, showed by contrast only weak activities in all of the above assay systems except for the lethality in galactosamine-loaded mice. This finding strongly suggests that the presence of acyloxyacyl groups at the C-2' and C-3' positions of the disaccharide backbone is one of the most important determinant structures of the lipid A molecule for exhibition of strong biological activities characteristic of lipopolysaccharide and its lipid A moiety. The activities of the corresponding 4'-monophosphate (compound 504) and 1-monophosphate (505) analogs were considerably less than those of the parent molecule 506 and the reference F515 lipid A. Regarding other biological activities, not only compound 506 but also compounds 504, 505, and 406 showed definite activities, sometimes comparable to those of F515 lipid A and other reference natural products. These are the activation of Tachypleus tridentatus amoebocyte clotting enzyme cascade and human complement via the classical pathway, mitogenic and polyclonal B-cell activation of murine splenocytes, stimulation of peritoneal macrophages in a guinea pig, enhancement of migration of human blood polymorphonuclear leukocytes, and induction of a serum factor that is cytostatic and cytocidal to L-929 cells in Mycobacterium bovis BCG-primed mice. Relative potencies of test synthetic compounds depended on the assay systems and varied from one system to another. Dephospho-compound 503 lacked most of the biological activities that were definitely observed with phosphorylated compounds, probably because of its insolubility. This study demonstrates the successful chemical synthesis of an E. coli-type lipid A.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891627      PMCID: PMC262083          DOI: 10.1128/iai.49.1.225-237.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  OBSERVATIONS ON MODE OF ACTION OF ENDOTOXIN IN CHICK EMBRYOS.

Authors:  R A FINKELSTEIN
Journal:  Proc Soc Exp Biol Med       Date:  1964-03

Review 2.  The effects of bacterial endotoxins on host mediation systems. A review.

Authors:  D C Morrison; R J Ulevitch
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

3.  Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse.

Authors:  S Green; A Dobrjansky; M A Chiasson; E Carswell; M K Schwartz; L J Old
Journal:  J Natl Cancer Inst       Date:  1977-11       Impact factor: 13.506

4.  Use of an antiglobulin serum to detect cells producing antibody with low haemolytic efficiency.

Authors:  D W Dresser; D H Wortis
Journal:  Nature       Date:  1965-11-27       Impact factor: 49.962

5.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

6.  Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever.

Authors:  V Baracos; H P Rodemann; C A Dinarello; A L Goldberg
Journal:  N Engl J Med       Date:  1983-03-10       Impact factor: 91.245

7.  Chemical structure and biological activities of lipid A's from various bacterial families.

Authors:  O Lüderitz; C Galanos; V Lehmann; H Mayer; E T Rietschel; J Weckesser
Journal:  Naturwissenschaften       Date:  1978-11

8.  Isolation, purification and properties of an intermediate in 3-deoxy-D-manno-octulosonic acid--lipid A biosynthesis.

Authors:  V Lehmann
Journal:  Eur J Biochem       Date:  1977-05-02

9.  Galactosamine-induced sensitization to the lethal effects of endotoxin.

Authors:  C Galanos; M A Freudenberg; W Reutter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

10.  Macrophage activation by muramyl dipeptide as measured by macrophage spreading and attachment.

Authors:  A Tanaka; S Nagao; K Imai; R Mori
Journal:  Microbiol Immunol       Date:  1980       Impact factor: 1.955

View more
  56 in total

1.  Local skin response in mice induced by a single intradermal injection of bacterial lipopolysaccharide and lipid A.

Authors:  Y Ishikawa; T Kirikae; M Hirata; M Yoshida; Y Haishima; S Kondo; K Hisatsune
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

2.  Concurrent lipopolysaccharide enhances chemotactic response of human polymorphonuclear leukocytes to bacterial chemotaxin.

Authors:  H R Creamer; N Hunter; W W Bullock; W L Gabler
Journal:  Inflammation       Date:  1991-06       Impact factor: 4.092

3.  [Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties].

Authors:  E T Rietschel; H Brade
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

4.  Induction of early gene expression in murine macrophages by synthetic lipid A analogs with differing endotoxic potentials.

Authors:  P Y Perera; C L Manthey; P L Stütz; J Hildebrandt; S N Vogel
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

Review 5.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

6.  Biological activities of chemically synthesized 2-keto-3-deoxyoctonic acid-(alpha 2----6)-D-glucosamine analogs of lipid A.

Authors:  T Shimizu; S Akiyama; T Masuzawa; Y Yanagihara; S Nakamoto; K Achiwa
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

7.  Relationship of structure and biological activity of monosaccharide lipid A analogues to induction of nitric oxide production by murine macrophage RAW264.7 cells.

Authors:  K Funatogawa; M Matsuura; M Nakano; M Kiso; A Hasegawa
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Low biological activity of Helicobacter pylori lipopolysaccharide.

Authors:  A Muotiala; I M Helander; L Pyhälä; T U Kosunen; A P Moran
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.

Authors:  I Takahashi; S Kotani; H Takada; M Tsujimoto; T Ogawa; T Shiba; S Kusumoto; M Yamamoto; A Hasegawa; M Kiso
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

10.  Immunobiological activities of synthetic lipid A analogs with low endotoxicity.

Authors:  S Kotani; H Takada; I Takahashi; T Ogawa; M Tsujimoto; H Shimauchi; T Ikeda; H Okamura; T Tamura; K Harada
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.